KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Adaptive Biotechnologies (ADPT) Cost of Revenue (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Cost of Revenue for 8 consecutive years, with $41.4 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 129.63% to $41.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.6 million through Dec 2025, up 23.87% year-over-year, with the annual reading at $94.6 million for FY2025, 31.2% up from the prior year.
  • Cost of Revenue hit $41.4 million in Q4 2025 for Adaptive Biotechnologies, up from $18.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $60.5 million in Q4 2021 to a low of $10.0 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $22.0 million across 5 years, with a median of $18.4 million in 2023.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 372.64% in 2021 and later plummeted 72.59% in 2022.
  • Year by year, Cost of Revenue stood at $60.5 million in 2021, then tumbled by 72.59% to $16.6 million in 2022, then skyrocketed by 96.77% to $32.6 million in 2023, then tumbled by 44.72% to $18.0 million in 2024, then skyrocketed by 129.63% to $41.4 million in 2025.
  • Business Quant data shows Cost of Revenue for ADPT at $41.4 million in Q4 2025, $18.2 million in Q3 2025, and $18.0 million in Q2 2025.